CV Sciences, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $278.0K | $454.0K | $1.3M | $611.0K | $1.4M | $4.0M | $9.1M | $12.7M |
| Accounts Receivable | $402.0K | $522.0K | $431.0K | $766.0K | $2.0M | $1.1M | $2.2M | $3.3M |
| Inventory | $4.1M | $4.9M | $5.7M | $6.6M | $8.6M | $8.8M | $10.0M | $7.1M |
| Total Current Assets | $5.1M | $6.2M | $7.9M | $11.1M | $14.2M | $16.9M | $32.4M | $25.5M |
| Property, Plant & Equipment | $344.0K | $399.0K | $379.0K | $575.0K | $1.7M | $2.9M | $3.6M | $2.8M |
| Goodwill | $1.0M | $971.0K | $342.0K | $0 | $0 | $2.8M | $2.8M | $2.8M |
| Intangible Assets (Excl. Goodwill) | $76.0K | $93.0K | $78.0K | $251.0K | $1.5M | $3.7M | $3.8M | $3.8M |
| Total Assets | $7.0M | $7.9M | $9.2M | $12.7M | $18.1M | $30.6M | $52.7M | $36.9M |
| Liabilities | ||||||||
| Accounts Payable | $1.0M | $1.9M | $2.3M | $2.3M | $2.6M | $1.7M | $1.6M | $1.2M |
| Total Current Liabilities | $5.0M | $6.1M | $6.1M | $13.3M | $14.5M | $14.3M | $13.2M | $4.4M |
| Long-Term Debt | $387.0K | $0 | — | — | $0 | $1.5M | — | — |
| Total Liabilities | $5.5M | $6.1M | $6.3M | $13.5M | $14.5M | $19.4M | $23.5M | $6.8M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-87.9M | $-87.0M | $-84.6M | $-87.7M | $-79.5M | $-63.9M | $-41.6M | $-25.0M |
| Total Stockholders' Equity | $1.5M | $1.8M | $2.9M | $-777.0K | $3.5M | $11.2M | $29.1M | $30.1M |